209 related articles for article (PubMed ID: 36466883)
41. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
Front Immunol; 2018; 9():2400. PubMed ID: 30386345
[TBL] [Abstract][Full Text] [Related]
42. Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation.
Mazerolles F; Stolzenberg MC; Pelle O; Picard C; Neven B; Fischer A; Magerus-Chatinet A; Rieux-Laucat F
Front Immunol; 2018; 9():718. PubMed ID: 29686686
[TBL] [Abstract][Full Text] [Related]
43. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.
Völkl S; Rensing-Ehl A; Allgäuer A; Schreiner E; Lorenz MR; Rohr J; Klemann C; Fuchs I; Schuster V; von Bueren AO; Naumann-Bartsch N; Gambineri E; Siepermann K; Kobbe R; Nathrath M; Arkwright PD; Miano M; Stachel KD; Metzler M; Schwarz K; Kremer AN; Speckmann C; Ehl S; Mackensen A
Blood; 2016 Jul; 128(2):227-38. PubMed ID: 27099149
[TBL] [Abstract][Full Text] [Related]
44. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders.
Oliveira Mendonça L; Matucci-Cerinic C; Terranova P; Casabona F; Bovis F; Caorsi R; Fioredda F; Palmisani E; Grossi A; Guardo D; Bustaffa M; Volpi S; Ceccherini I; Ravelli A; Dufour C; Miano M; Gattorno M
Rheumatology (Oxford); 2022 Feb; 61(2):696-704. PubMed ID: 33909886
[TBL] [Abstract][Full Text] [Related]
45. Elevated double negative T cells in pediatric autoimmunity.
Tarbox JA; Keppel MP; Topcagic N; Mackin C; Ben Abdallah M; Baszis KW; White AJ; French AR; Cooper MA
J Clin Immunol; 2014 Jul; 34(5):594-9. PubMed ID: 24760111
[TBL] [Abstract][Full Text] [Related]
46. Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD.
Gu H; Chen Z; Ma J; Wang J; Zhang R; Wu R; Wang T
Int J Immunopathol Pharmacol; 2021; 35():20587384211025934. PubMed ID: 34187243
[TBL] [Abstract][Full Text] [Related]
47. Case report: Effectiveness of sirolimus in a
Gu H; Chen Z; Ma J; Ma J; Fu L; Zhang R; Wang T; Wu R
Front Pediatr; 2022; 10():868193. PubMed ID: 35967554
[TBL] [Abstract][Full Text] [Related]
48. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
Price S; Shaw PA; Seitz A; Joshi G; Davis J; Niemela JE; Perkins K; Hornung RL; Folio L; Rosenberg PS; Puck JM; Hsu AP; Lo B; Pittaluga S; Jaffe ES; Fleisher TA; Rao VK; Lenardo MJ
Blood; 2014 Mar; 123(13):1989-99. PubMed ID: 24398331
[TBL] [Abstract][Full Text] [Related]
49. [Advances in the knowledge and management of autoimmune lymphoproliferative syndrome].
Garrido Colino C
An Pediatr (Barc); 2014 Feb; 80(2):122.e1-7. PubMed ID: 24055319
[TBL] [Abstract][Full Text] [Related]
50. Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults.
Lambotte O; Neven B; Galicier L; Magerus-Chatinet A; Schleinitz N; Hermine O; Meyts I; Picard C; Godeau B; Fischer A; Rieux-Laucat F
Haematologica; 2013 Mar; 98(3):389-92. PubMed ID: 22983577
[TBL] [Abstract][Full Text] [Related]
51. Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.
Magerus-Chatinet A; Stolzenberg MC; Lanzarotti N; Neven B; Daussy C; Picard C; Neveux N; Desai M; Rao M; Ghosh K; Madkaikar M; Fischer A; Rieux-Laucat F
J Allergy Clin Immunol; 2013 Feb; 131(2):486-90. PubMed ID: 22857792
[TBL] [Abstract][Full Text] [Related]
52. Expanding the clinical phenotype of FADD deficiency with a novel mutation and its role in Fas-mediated apoptotic pathway.
Setia P; Bargir UA; Shanmukhaiah C; Jodhawat N; Gaikwad P; Vedpathak D; Dutta S; Kulkarni R; Kambli P; Dalvi A; Shinde S; Gupta M; Nambiar N; Sawant S; Shelar S; Dhawale A; Mohanty M; Yadav RM; Bose K; Madkaikar M
Br J Haematol; 2023 Jul; 202(2):e11-e15. PubMed ID: 37199216
[No Abstract] [Full Text] [Related]
53. [Autoimmune lymphoproliferative syndrome: a case report].
Youssif HB; Ailal F; Benhsaien I; Bakkouri JE; Jeddane L; Maani KE; Bousfiha AA
Pan Afr Med J; 2022; 43():61. PubMed ID: 36523284
[TBL] [Abstract][Full Text] [Related]
54. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
[TBL] [Abstract][Full Text] [Related]
55. Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features.
Kurita D; Shiba N; Ohya T; Murase A; Shimosato Y; Yoshitomi M; Hattori S; Sasaki K; Nishimura K; Tsujimoto SI; Takeuchi M; Tanoshima R; Kanegane H; Kitagawa N; Ito S
J Clin Immunol; 2023 Nov; 43(8):1992-1996. PubMed ID: 37644277
[TBL] [Abstract][Full Text] [Related]
56. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
[TBL] [Abstract][Full Text] [Related]
57. The genetic landscape of the FAS pathway deficiencies.
Magerus A; Bercher-Brayer C; Rieux-Laucat F
Biomed J; 2021 Aug; 44(4):388-399. PubMed ID: 34171534
[TBL] [Abstract][Full Text] [Related]
58. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
[TBL] [Abstract][Full Text] [Related]
59. Synergistic defects of novo FAS and homozygous UNC13D leading to autoimmune lymphoproliferative syndrome-like disease: A 10-year-old Chinese boy case report.
Gu H; Ma J; Chen Z; Wang J; Zhang R; Wu R
Gene; 2018 Sep; 672():45-49. PubMed ID: 29864493
[TBL] [Abstract][Full Text] [Related]
60. Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients.
Ben-Mustapha I; Agrebi N; Barbouche MR
J Leukoc Biol; 2018 Mar; 103(3):501-508. PubMed ID: 29345341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]